ALPS Advisors’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-29,843
Closed -$97K 894
2017
Q3
$97K Buy
29,843
+2,612
+10% +$35.2K ﹤0.01% 765
2017
Q2
$513K Buy
27,231
+1,255
+5% +$17.5K ﹤0.01% 466
2017
Q1
$318K Sell
25,976
-3,038
-10% -$44.2K ﹤0.01% 686
2016
Q4
$461K Sell
29,014
-9,446
-25% -$158K ﹤0.01% 479
2016
Q3
$700K Sell
38,460
-3,844
-9% -$62.8K 0.01% 242
2016
Q2
$672K Buy
42,304
+9,425
+29% +$141K 0.01% 221
2016
Q1
$491K Buy
32,879
+950
+3% +$14.9K 0.01% 227
2015
Q4
$886K Sell
31,929
-5,845
-15% -$145K 0.01% 221
2015
Q3
$673K Buy
37,774
+13,855
+58% +$328K 0.01% 235
2015
Q2
$550K Buy
+23,919
New +$671K ﹤0.01% 388

Other funds holding OTIC

ALPS Advisors's OTIC Position: Q4 2017 in Review

ALPS Advisors sold out of Otonomy, Inc. (OTIC) in Q4 2017, closing a stake of 29,843 shares — an estimated $97K sold.

ALPS Advisors first reported a position in OTIC in Q2 2015 and held it in 10 quarters. The position peaked at $886K in Q4 2015. 83 funds tracked by Wall St. Rank hold OTIC as of Q4 2017.

  • ALPS Advisors reported no remaining Otonomy, Inc. position as of Q4 2017 after selling out during the quarter.
  • ALPS Advisors sold 29,843 Otonomy, Inc. shares in Q4 2017, an estimated $97K.
  • ALPS Advisors first reported a position in Otonomy, Inc. in Q2 2015 and held it in 10 quarters.
  • ALPS Advisors's Otonomy, Inc. position peaked at $886K in Q4 2015.
  • 83 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q4 2017.

Based on ALPS Advisors's 13F filing for Q4 2017, filed 5 Feb 2018.